scispace - formally typeset
S

Sushil Kumar Shakyawar

Researcher at University of Nebraska Medical Center

Publications -  13
Citations -  1248

Sushil Kumar Shakyawar is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Medicine & Similarity (geometry). The author has an hindex of 6, co-authored 11 publications receiving 584 citations. Previous affiliations of Sushil Kumar Shakyawar include University of Minho & Indian Institute of Technology Guwahati.

Papers
More filters
Journal ArticleDOI

Big data in healthcare: management, analysis and future prospects

TL;DR: To provide relevant solutions for improving public health, healthcare providers are required to be fully equipped with appropriate infrastructure to systematically generate and analyze big data.
Journal ArticleDOI

Toward more realistic drug–target interaction predictions

TL;DR: In this paper, the effects of four factors that may lead to dramatic differences in the prediction results are investigated: (i) problem formulation (standard binary classification or more realistic regression formulation), (ii) evaluation data set (drug and target families in the application use case), (iii) evaluation procedure (simple or nested cross-validation) and (iv) experimental setting (whether training and test sets share common drugs and targets, only drugs or targets or neither).
Journal ArticleDOI

Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis.

TL;DR: A systematic evaluation of target selectivity profiles across three recent large-scale biochemical assays of kinase inhibitors and further compared these standardized bioactivity assays with data reported in the widely used databases ChEMBL and STITCH revealed relative benefits and potential limitations among the bioactivity types.
Journal ArticleDOI

Systematic Mapping of Kinase Addiction Combinations in Breast Cancer Cells by Integrating Drug Sensitivity and Selectivity Profiles

TL;DR: A chemical systems biology approach that integrates comprehensive drug sensitivity and selectivity profiling to provide functional insights into both single and multi-target oncogenic signal addictions is developed.